Phase II evaluation of carboplatin, paclitaxel and gemcitabine followed by concurrent cisplatin and radiation therapy in patients with locally advanced or recurrent urothelial malignancy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Cisplatin; Gemcitabine; Paclitaxel
- Indications Urogenital cancer
- Focus Pharmacogenomic; Therapeutic Use
- 31 Jan 2013 Biomarkers information updated
- 29 Aug 2005 New trial record.